Harnessing a revolution in targeting chemistry

Centrose is attaching novel sugars and targeting molecules to enhance the pharmaceutical properties of drugs with established therapeutic potential.

Using the power of CarboConnect® and its sophisticated understanding of cell targeting biology, Centrose is growing its drug pipeline. Cells containing specialized sugars behave quite differently than those that do not.  The same can be said for drugs. When attached to drugs, certain sugar types substantially change drug function. Centrose is pioneering scientific breakthroughs in the understanding of sugar chemistry and sugar targeting biology in order to rapidly develop a diverse pipeline of proprietary therapeutics.

Our mission at Centrose is to discover new ways to make better drugs.

figure 1a: anticancer

Examples of how sugars can activate and enhance small molecule therapeutics.

The sugars are in Gold. The small molecule scaffolds are in Black.

figure 1a: antibacterial

 

Recent Press Releases


01/12/2010
Troy Wilson Appointed to Board

09/14/2009
Cancer Lead Shows Low Toxicity

09/02/2009
Centrose Selected to Present at BioPharm America

 view all press releases

 
Privacy Policy :: Legal :: Site Map